この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2004/9/281 分で読めます
Cumulative List of Exceptions and Alternative Procedures Approved by the Director of the Center for Biologics Evaluation and Research
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing the availability a cumulative list of exceptions and alternative procedures to requirements regarding blood, blood components, and blood products that have been approved by the Director of the Center for Biologics Evaluation and Research (CBER). Also, FDA is announcing that this list is posted on the Internet and it will be periodically updated.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →